Please use this identifier to cite or link to this item: https://hdl.handle.net/10216/151692
Full metadata record
DC FieldValueLanguage
dc.creatorMota, D-
dc.creatorRama, TA-
dc.creatorMoreira, A-
dc.date.accessioned2023-08-02T10:18:02Z-
dc.date.available2023-08-02T10:18:02Z-
dc.date.issued2023-
dc.identifier.issn0105-4538-
dc.identifier.issn1398-9995-
dc.identifier.urihttps://hdl.handle.net/10216/151692-
dc.description.abstractNo abstract available-
dc.language.isoeng-
dc.publisherWiley-
dc.relation.ispartofAllergy. 2023 May;78(5):1375-1377. doi: 10.1111/all.15628. Epub 2023 Jan 11.-
dc.rightsopenAccess-
dc.rights.urihttps://creativecommons.org/licenses/by-nc/4.0/-
dc.titleReal-world evidence on the risk of cancer with anti-IL-5 and anti-IL-4Ra biologicals-
dc.typeOutra Publicação em Revista Científica Internacional-
dc.contributor.uportoInstituto de Saúde Pública da Universidade do Porto-
dc.identifier.doi10.1111/all.15628-
dc.relation.publisherversionhttps://onlinelibrary.wiley.com/doi/10.1111/all.15628-
Appears in Collections:ISPUP - Outra Publicação em Revista Científica Internacional

Files in This Item:
File Description SizeFormat 
mota-a-2022.pdf1.77 MBAdobe PDFThumbnail
View/Open


This item is licensed under a Creative Commons License Creative Commons